Lyndra Therapeutics

Lyndra Therapeutics is a biotechnology company focused on reinventing medicine by developing long-acting oral therapies that dramatically reduce dosing frequency. Their proprietary LYNX® drug delivery platform uses patented innovations in design, engineering, and materials science to deliver medicines for a week or longer in an oral form, potentially improving adherence, reducing side effects, and simplifying patient lives. Lyndra is developing therapies for a range of therapeutic areas including CNS conditions, cardiovascular and cardiometabolic diseases, opioid use disorder, malaria eradication, and pregnancy prevention, with a particular focus on increasing access to treatment for underserved populations.

Lyndra's culture is one of innovation, inclusion, and a commitment to making a positive impact on the world. They value diversity and equity, and they believe that a range of backgrounds and perspectives is critical to their success. They are actively working to build a team of talented and passionate individuals who are inspired by their mission to reinvent medicine for a healthier world.

Lyndra Therapeutics offers flexible work arrangements to its employees, allowing them to work in a way that best suits their individual needs and preferences. This includes options for flexible work schedules, remote work, and hybrid work models, depending on the specific role and employee needs. This approach empowers employees to maintain a healthy work-life balance and contribute to the company's success in a way that aligns with their individual circumstances.

Lyndra Therapeutics offers a comprehensive benefits package to its full-time employees, including competitive salaries, an annual bonus program, and equity. They prioritize a flexible work environment with remote and hybrid options available depending on the role. Beyond financial benefits, Lyndra fosters a people-first culture that emphasizes learning and development, valuing every voice, and investing in internal talent.

Lyndra Therapeutics is a biopharmaceutical company dedicated to reinventing medicine for a healthier world by pioneering long-acting oral therapies that offer patients freedom from daily pills. The company's LYNX® drug delivery platform is designed to deliver medicine for a week or longer in an oral form, transforming the patient experience and simplifying their lives. This innovative approach has the potential to improve adherence, reduce the burden of daily medication, and ultimately enhance treatment outcomes across multiple therapeutic areas.

Lyndra promotes a culture that is dynamic, empowering, and focused on innovation. They value diversity of identity, experience, and perspectives, believing that this drives innovation and success. They welcome, value, and promote equality and individuality, ensuring that every voice is heard and valued. Their core purpose is to "reinvent medicine for a healthier world," and they strive to create an environment where employees feel empowered to contribute, break barriers, and make a difference.

Lyndra Therapeutics values diversity and believes it drives innovation. They actively promote a culture of inclusion and equality, welcoming individuals with a range of backgrounds, experiences, and perspectives. Their executive team and board reflect this commitment, with more than half of the workforce being female. Employees are empowered through leadership roles in diversity and inclusion committees and participate in employee-driven affinity groups. This deliberate approach to diversity and inclusion sets Lyndra apart as a company that prioritizes a welcoming and equitable environment for all.